Literature DB >> 14754376

Expression of opioid receptors during peripheral inflammation.

Olga Pol1, Margarita M Puig.   

Abstract

Opioid receptors (OR) and their mRNA are present in the central and peripheral nervous system of mammals. In this review we examine the behavioral effects of opioids and the expression of their receptors during peripheral inflammation in two experimental models: the rat paw and the mouse intestine. Inflammation increased the antinociceptive (paw) and the inhibitory effects of opioids in the gut (transit, permeability and plasma extravasation) by interaction with OR located at peripheral sites. Based on agonist efficacy, micro > delta >> kappa-OR mediate the antinociceptive and antitransit effects of opioids during inflammation. Intestinal permeability is modulated by delta = micro >> kappa-OR, while kappa > delta >> micro-OR are involved in the inhibition of plasma extravasation. Intestinal inflammation increased the transcription of micro and delta-OR (but not kappa) genes in the gut, thus explaining the enhanced antitransit and antisecretory effects of micro and delta-OR agonists; however, the increased inhibitory effects of kappa-OR agonists on plasma extravasation could result from post-transcriptional regulation of the receptor. Similarly, the increased expression of peripheral micro-OR observed in the rat paw during inflammation, occurs at post-transcriptional levels and is related to an increased axonal transport from the dorsal root ganglia to peripheral terminals. The sites and mechanisms implicated in the increased transcription of micro and delta-OR during intestinal inflammation are under investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14754376     DOI: 10.2174/1568026043451519

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  21 in total

1.  Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective.

Authors:  Emily O Dumas; Gary M Pollack
Journal:  AAPS J       Date:  2008-11-07       Impact factor: 4.009

2.  Sex differences in μ-opioid receptor expression in trigeminal ganglia under a myositis condition in rats.

Authors:  X Zhang; Y Zhang; J Asgar; K Y Niu; J Lee; K S Lee; M Schneider; J Y Ro
Journal:  Eur J Pain       Date:  2013-06-25       Impact factor: 3.931

3.  Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.

Authors:  D Philippe; D Chakass; X Thuru; P Zerbib; A Tsicopoulos; K Geboes; P Bulois; M Breisse; H Vorng; J Gay; J-F Colombel; P Desreumaux; M Chamaillard
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

4.  Involvement of central opioid receptors in protective effects of methadone on experimental colitis in rats.

Authors:  Nahid Fakhraei; Nina Javadian; Reza Rahimian; Fatemeh Nili; Nastaran Rahimi; Shiva Hashemizadeh; Ahmad Reza Dehpour
Journal:  Inflammopharmacology       Date:  2018-10-15       Impact factor: 4.473

5.  Effects of the local administration of selective mu-, delta-and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia.

Authors:  Ana Baamonde; Ana Lastra; Lucía Juárez; Verónica García; Agustín Hidalgo; Luis Menéndez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-11-08       Impact factor: 3.000

6.  Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial.

Authors:  Jill P Smith; Sandra I Bingaman; Francesca Ruggiero; David T Mauger; Aparna Mukherjee; Christopher O McGovern; Ian S Zagon
Journal:  Dig Dis Sci       Date:  2011-03-08       Impact factor: 3.199

7.  The involvement of nitric oxide in the enhanced expression of mu-opioid receptors during intestinal inflammation in mice.

Authors:  Olga Pol; Masayuki Sasaki; Natàlia Jiménez; Valina L Dawson; Ted M Dawson; Margarita M Puig
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

8.  micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.

Authors:  Dania Chakass; David Philippe; Edmone Erdual; Sébastien Dharancy; Mathilde Malapel; Caroline Dubuquoy; Xavier Thuru; Jerome Gay; Claire Gaveriaux-Ruff; Pierre Dubus; Philippe Mathurin; Brigitte L Kieffer; Pierre Desreumaux; Mathias Chamaillard
Journal:  Gut       Date:  2007-02-13       Impact factor: 23.059

9.  Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.

Authors:  R Capasso; F Borrelli; M G Cascio; G Aviello; K Huben; J K Zjawiony; P Marini; B Romano; V Di Marzo; F Capasso; A A Izzo
Journal:  Br J Pharmacol       Date:  2008-07-14       Impact factor: 8.739

10.  Pain-Relieving Effectiveness of Co-Treatment with Local Tramadol and Systemic Minocycline in Carrageenan-Induced Inflammatory Pain Model.

Authors:  Tufan Mert; Emel Sahin; Selma Yaman; Mehmet Sahin
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.